STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

David Buchebner

MD. PhD, specialised in Endochrinology

David Buchebner, MD, PhD, is a specialist in endocrinology. He is Chief Medical Officer at Yazen and Quality Assurance Manager at Yazen Health and contributes with scientific expertise in endocrinology and metabolic disease.

LinkedIn logo
Portrait imageOrange stylized human head with colorful flowers and vines growing out from the top and back.

David Buchebner, MD, PhD, is an endocrinologist with a strong clinical and research background in metabolic and bone health. He completed his doctoral studies in osteoporosis at Lund University and earned his medical degree from the Medical University of Vienna.

His primary scientific interests include osteoporosis, vitamin D, overweight and obesity, and broader aspects of internal medicine within endocrinology.

He has combined extensive clinical experience with research and development work at Hallands Hospital Halmstad and within Region Halland.

Since 2024, David has been part of Yazen Health, initially serving as Quality Assurance Manager, where he contributed to the further development of our evidence-based obesity care. He currently holds the position of Chief Medical Officer, where he leads medical strategy and ensures clinical excellence across the organization.

Articles by

David Buchebner

Science and publications

High Adherence to GLP-1 Receptor Agonists: 18-Month Outcomes from the Yazen Model

High adherence rates to GLP-1 receptor agonists within a structured, digitally based weight management programme, may contribute to improved long-term medication adherence.
‍
Summary‍

This real-world analysis from Yazens first large scale operational quality follow-up, demonstrates almost 70% compliance with GLP-1 medications at 12 months, surpassing earlier studies that showed 20-50%1-4. After 2 years*, 60% of patients were still in treatment.